Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Martin Zamora

Concepts (273)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Transplantation
31
2023
246
6.150
Why?
Cytomegalovirus Infections
7
2012
182
1.780
Why?
Antiviral Agents
12
2023
646
1.550
Why?
Respiratory Syncytial Virus Infections
4
2023
98
1.380
Why?
Lung Diseases
7
2017
696
1.170
Why?
Postoperative Complications
9
2015
2127
0.850
Why?
Bronchiolitis Obliterans
7
2015
66
0.820
Why?
Ganciclovir
5
2012
49
0.810
Why?
Respiratory Syncytial Virus, Human
1
2023
61
0.800
Why?
alpha 1-Antitrypsin Deficiency
2
2018
69
0.610
Why?
Graft Rejection
9
2018
516
0.590
Why?
Pneumonia, Viral
1
2023
340
0.590
Why?
Heart Transplantation
6
2016
667
0.570
Why?
Lung
11
2017
3546
0.550
Why?
Pulmonary Medicine
1
2017
87
0.540
Why?
Regeneration
1
2017
160
0.520
Why?
Sirolimus
3
2018
181
0.510
Why?
Diltiazem
1
2014
23
0.470
Why?
Bronchial Arteries
2
2010
11
0.450
Why?
RNA, Small Interfering
2
2015
543
0.410
Why?
Organ Transplantation
3
2018
159
0.410
Why?
Transplant Recipients
1
2014
140
0.410
Why?
Graft Survival
5
2018
452
0.400
Why?
Pulmonary Circulation
2
2010
406
0.380
Why?
Patient Selection
6
2015
641
0.370
Why?
Polymorphism, Genetic
1
2014
612
0.370
Why?
Histocompatibility Antigens Class I
1
2012
174
0.360
Why?
Epstein-Barr Virus Infections
1
2011
72
0.360
Why?
Transplantation, Homologous
10
2018
386
0.350
Why?
Histocompatibility Antigens Class II
1
2012
353
0.350
Why?
Herpesviridae Infections
1
2011
138
0.350
Why?
RNA Interference
2
2013
437
0.340
Why?
Treatment Outcome
10
2023
9089
0.330
Why?
Pulmonary Emphysema
4
2015
268
0.330
Why?
Societies, Medical
4
2018
663
0.330
Why?
Virus Diseases
1
2011
195
0.330
Why?
Respiratory Tract Infections
1
2011
319
0.290
Why?
Humans
41
2023
114716
0.280
Why?
Cytomegalovirus
2
2004
144
0.270
Why?
Gene Expression Regulation
3
2014
2321
0.270
Why?
Pulmonary Disease, Chronic Obstructive
5
2015
916
0.250
Why?
Capillaries
1
2005
91
0.250
Why?
Autoantibodies
2
2013
1350
0.250
Why?
Vasculitis
1
2005
70
0.250
Why?
Immunosuppressive Agents
4
2014
647
0.240
Why?
Drug Resistance, Viral
3
2011
99
0.240
Why?
Waiting Lists
3
2015
211
0.230
Why?
Immunoglobulins, Intravenous
1
2004
122
0.220
Why?
Reperfusion Injury
3
2017
254
0.220
Why?
Lymphocyte Function-Associated Antigen-1
2
2018
34
0.220
Why?
Risk Factors
7
2013
8626
0.220
Why?
Heart-Lung Transplantation
2
2014
9
0.210
Why?
Pneumonectomy
2
2018
125
0.210
Why?
Consensus
2
2016
535
0.210
Why?
Evidence-Based Medicine
1
2005
667
0.190
Why?
Middle Aged
14
2015
26746
0.170
Why?
Transplantation Tolerance
1
2018
31
0.160
Why?
Endothelial Cells
2
2013
681
0.150
Why?
Primary Graft Dysfunction
2
2017
30
0.150
Why?
Bronchoalveolar Lavage Fluid
4
2020
589
0.140
Why?
Adult
9
2023
30543
0.140
Why?
Transplantation, Heterotopic
2
2014
16
0.140
Why?
Male
18
2015
55558
0.140
Why?
CD4-Positive T-Lymphocytes
2
2014
965
0.140
Why?
Respiratory Function Tests
2
2010
524
0.140
Why?
Immune Tolerance
1
2018
328
0.130
Why?
Frailty
1
2018
114
0.130
Why?
DNA, Mitochondrial
1
2017
182
0.130
Why?
Syndrome
3
2015
334
0.130
Why?
Congresses as Topic
1
2017
196
0.130
Why?
Tissue Donors
2
2016
317
0.130
Why?
Female
17
2018
59486
0.130
Why?
International Cooperation
1
2016
172
0.120
Why?
Follow-Up Studies
3
2014
4420
0.120
Why?
Interleukin-18
2
2013
219
0.120
Why?
Fas Ligand Protein
1
2014
58
0.120
Why?
Asphyxia
1
2014
21
0.120
Why?
Tissue and Organ Procurement
2
2015
228
0.120
Why?
Cytochrome P-450 CYP2C8
1
2014
15
0.120
Why?
Extracorporeal Membrane Oxygenation
2
2015
240
0.120
Why?
Receptors, Steroid
1
2014
47
0.110
Why?
Aryl Hydrocarbon Hydroxylases
1
2014
41
0.110
Why?
Everolimus
1
2014
61
0.110
Why?
Anastomosis, Surgical
2
2013
136
0.110
Why?
Perfusion
1
2014
145
0.110
Why?
Cytochrome P-450 CYP3A
1
2014
62
0.110
Why?
Tobacco Smoke Pollution
2
2013
217
0.110
Why?
Tissue Distribution
1
2014
285
0.110
Why?
Health Resources
1
2015
122
0.110
Why?
Ventilator-Induced Lung Injury
1
2014
49
0.110
Why?
CD146 Antigen
1
2013
35
0.110
Why?
CD8-Positive T-Lymphocytes
1
2018
689
0.110
Why?
Demography
1
2014
262
0.110
Why?
Practice Guidelines as Topic
2
2018
1393
0.100
Why?
Animals
12
2018
31761
0.100
Why?
Predictive Value of Tests
3
2013
1795
0.100
Why?
Immunocompromised Host
2
2011
195
0.100
Why?
Vasodilator Agents
1
2014
303
0.100
Why?
Metabolic Clearance Rate
1
2012
102
0.100
Why?
Injections, Intravenous
1
2012
201
0.100
Why?
Liver Transplantation
1
2018
706
0.100
Why?
Seroepidemiologic Studies
1
2012
138
0.100
Why?
Cytokines
2
2010
1843
0.090
Why?
Double-Blind Method
2
2015
1662
0.090
Why?
Viral Vaccines
1
2011
88
0.090
Why?
Length of Stay
1
2015
949
0.090
Why?
Respiration, Artificial
1
2014
526
0.090
Why?
Cell Communication
1
2012
279
0.090
Why?
Airway Remodeling
1
2010
57
0.090
Why?
Cross-Over Studies
1
2012
440
0.090
Why?
Neprilysin
1
2010
47
0.090
Why?
Referral and Consultation
1
2014
632
0.080
Why?
Gene Expression
1
2014
1420
0.080
Why?
Preoperative Care
1
2012
317
0.080
Why?
CD4 Antigens
1
2010
124
0.080
Why?
Cost of Illness
1
2011
254
0.080
Why?
Biomarkers
3
2014
3414
0.080
Why?
Adoptive Transfer
1
2010
198
0.080
Why?
T-Lymphocytes, Cytotoxic
1
2010
155
0.080
Why?
Pulmonary Artery
2
2012
1012
0.080
Why?
Pulmonary Fibrosis
2
2013
322
0.080
Why?
Genotype
1
2014
1773
0.080
Why?
Administration, Inhalation
1
2010
642
0.080
Why?
Blood Specimen Collection
1
2008
31
0.080
Why?
Regional Blood Flow
1
2010
424
0.080
Why?
Macrophages
2
2013
1261
0.080
Why?
Bacteriological Techniques
1
2008
65
0.080
Why?
C-Reactive Protein
1
2010
362
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
928
0.080
Why?
Recurrence
1
2011
936
0.080
Why?
Macrophages, Alveolar
2
2013
347
0.080
Why?
Body Temperature
1
2008
208
0.070
Why?
Dose-Response Relationship, Drug
1
2012
1846
0.070
Why?
Nurse Practitioners
1
2008
102
0.070
Why?
Fever
1
2008
279
0.070
Why?
Time Factors
5
2015
6124
0.070
Why?
Trachea
2
2007
223
0.070
Why?
Bacteremia
1
2008
159
0.070
Why?
Terminology as Topic
1
2007
187
0.070
Why?
Prognosis
1
2014
3334
0.070
Why?
Mice, Inbred BALB C
3
2018
1151
0.060
Why?
Aged
7
2014
19079
0.060
Why?
Practice Patterns, Physicians'
1
2014
1178
0.060
Why?
Antibodies, Monoclonal
2
2018
1270
0.060
Why?
Cryptogenic Organizing Pneumonia
1
2005
17
0.060
Why?
Mice
8
2014
14916
0.060
Why?
Tissue Transplantation
1
2005
11
0.060
Why?
Calcineurin Inhibitors
1
2005
58
0.060
Why?
CD40 Ligand
1
2005
41
0.060
Why?
Rats
4
2013
4943
0.060
Why?
Survival
1
2004
37
0.060
Why?
Mice, Inbred C3H
2
2018
241
0.060
Why?
T-Lymphocytes
1
2012
1745
0.060
Why?
Registries
1
2012
1759
0.060
Why?
Immunoglobulins
1
2004
143
0.060
Why?
Drug Resistance
1
2004
158
0.060
Why?
Cross-Sectional Studies
1
2014
4406
0.060
Why?
Hypoxia
1
2010
957
0.060
Why?
Rats, Sprague-Dawley
3
2013
2209
0.060
Why?
Drug Administration Schedule
1
2005
718
0.050
Why?
Torsion Abnormality
1
2003
17
0.050
Why?
Quality Assurance, Health Care
1
2005
311
0.050
Why?
Capillary Permeability
2
2013
135
0.050
Why?
Respiratory Mucosa
1
2005
251
0.050
Why?
Fibrosis
1
2005
453
0.050
Why?
Prevalence
1
2009
2249
0.050
Why?
Incidence
1
2009
2312
0.050
Why?
Young Adult
3
2014
10462
0.050
Why?
Mice, Inbred C57BL
3
2018
4710
0.050
Why?
Genomics
1
2006
639
0.050
Why?
Mice, Transgenic
2
2018
1951
0.050
Why?
Polymerase Chain Reaction
1
2004
994
0.050
Why?
Endothelium, Vascular
1
2007
843
0.050
Why?
Neutrophils
1
2006
1163
0.050
Why?
Mice, Knockout
3
2013
2582
0.050
Why?
Prospective Studies
1
2012
6216
0.050
Why?
Polyphosphates
1
2020
33
0.040
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2013
86
0.040
Why?
Transplantation Immunology
2
2013
30
0.040
Why?
Adolescent
4
2014
17808
0.040
Why?
Case-Control Studies
3
2013
3004
0.040
Why?
Early Diagnosis
2
2013
216
0.040
Why?
Ribavirin
1
2020
89
0.040
Why?
Mice, Inbred Strains
2
2013
396
0.040
Why?
Health Care Rationing
1
2018
45
0.040
Why?
Retrospective Studies
3
2015
12513
0.040
Why?
CD28 Antigens
1
2018
47
0.040
Why?
Immunohistochemistry
2
2013
1635
0.040
Why?
Gene Expression Profiling
1
2004
1521
0.040
Why?
Cyclosporine
1
2018
161
0.040
Why?
Cell Line
2
2013
2639
0.040
Why?
DNA Repair
1
2017
186
0.030
Why?
Acute Disease
2
2010
912
0.030
Why?
Isoantibodies
1
2016
57
0.030
Why?
Cell Movement
2
2012
867
0.030
Why?
DNA Damage
1
2017
357
0.030
Why?
Genes, RAG-1
1
2014
11
0.030
Why?
Reactive Oxygen Species
1
2017
536
0.030
Why?
Lymphocyte Activation
1
2018
1044
0.030
Why?
Tidal Volume
1
2014
75
0.030
Why?
Positive-Pressure Respiration
1
2014
68
0.030
Why?
Sensitivity and Specificity
2
2008
1690
0.030
Why?
Chemokine CCL5
1
2013
45
0.030
Why?
Patient Admission
1
2015
176
0.030
Why?
Gene Deletion
1
2014
356
0.030
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2013
66
0.030
Why?
Aorta, Abdominal
1
2013
39
0.030
Why?
Pulmonary Edema
1
2013
114
0.030
Why?
Immunity, Innate
1
2018
723
0.030
Why?
Neck
1
2013
83
0.030
Why?
Abdomen
1
2013
100
0.030
Why?
Child
1
2011
18352
0.030
Why?
Inhalation Exposure
1
2013
97
0.030
Why?
History, 21st Century
1
2013
160
0.030
Why?
Rats, Nude
1
2012
26
0.030
Why?
Cardiomegaly
1
2013
157
0.030
Why?
Tobacco Products
1
2013
98
0.030
Why?
Fluoresceins
1
2012
46
0.020
Why?
History, 20th Century
1
2013
265
0.020
Why?
Cell Death
1
2013
322
0.020
Why?
Intercellular Signaling Peptides and Proteins
1
2013
350
0.020
Why?
Familial Primary Pulmonary Hypertension
1
2012
190
0.020
Why?
Survival Rate
1
2015
1642
0.020
Why?
Transfection
1
2013
870
0.020
Why?
United States
2
2018
12176
0.020
Why?
Myocytes, Cardiac
1
2014
448
0.020
Why?
Aorta, Thoracic
1
2013
254
0.020
Why?
Vascular Endothelial Growth Factor A
1
2013
498
0.020
Why?
Fluorescent Dyes
1
2012
300
0.020
Why?
H-2 Antigens
1
2010
110
0.020
Why?
Myocardium
1
2014
908
0.020
Why?
Oximetry
1
2010
81
0.020
Why?
Patient Discharge
1
2015
769
0.020
Why?
False Positive Reactions
1
2008
108
0.020
Why?
Weight Loss
1
2013
642
0.020
Why?
Suicide
1
2014
502
0.020
Why?
Bronchoscopy
1
2010
246
0.020
Why?
Systemic Inflammatory Response Syndrome
1
2008
70
0.020
Why?
International Agencies
1
2007
30
0.020
Why?
Receptors, Interleukin-8B
1
2007
23
0.020
Why?
Blotting, Western
1
2010
1151
0.020
Why?
Pulmonary Alveoli
1
2010
372
0.020
Why?
Decompression, Surgical
1
2008
93
0.020
Why?
Microcirculation
1
2007
135
0.020
Why?
Evidence-Based Practice
1
2008
185
0.020
Why?
Biopsy, Needle
1
2007
181
0.020
Why?
Cell Survival
1
2010
1021
0.020
Why?
Chemotaxis, Leukocyte
1
2006
129
0.020
Why?
Reoperation
1
2008
514
0.020
Why?
Cells, Cultured
1
2013
3890
0.020
Why?
Oxygen
1
2010
853
0.020
Why?
Eosinophilia
1
2007
186
0.020
Why?
Transplantation Chimera
1
2005
51
0.020
Why?
Inpatients
1
2008
378
0.020
Why?
Models, Biological
1
2012
1630
0.020
Why?
Cell Proliferation
1
2012
2196
0.020
Why?
Ischemia
1
2007
362
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2006
743
0.010
Why?
Biopsy
1
2007
1040
0.010
Why?
Disease Models, Animal
1
2013
3542
0.010
Why?
Respiratory System
1
2005
137
0.010
Why?
Diagnosis, Differential
1
2007
1340
0.010
Why?
Kinetics
1
2006
1550
0.010
Why?
Surveys and Questionnaires
1
2014
4622
0.010
Why?
Pneumonia
1
2007
566
0.010
Why?
Reproducibility of Results
1
2008
2762
0.010
Why?
Chronic Disease
1
2007
1590
0.010
Why?
Immunotherapy
1
2005
475
0.010
Why?
Hypertension, Pulmonary
1
2012
1728
0.010
Why?
Tomography, X-Ray Computed
1
2010
2269
0.010
Why?
Transcription, Genetic
1
2004
1316
0.010
Why?
RNA, Messenger
1
2004
2557
0.010
Why?
Inflammation
1
2005
2481
0.010
Why?
Zamora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)